v3.22.1
Operating segments
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Operating segments

12. Operating segments

 

The Company has one operating segment, development of diabetes hardware and software. The Company’s geographical segments are summarized as follows:

 

          
   December 31,
2021
  December 31,
2020
       
Current and Total Assets          
Other  $9,547   $7,632 
Singapore   110,527    20,000 
  United States   73,143    101,217 
   $193,217   $128,849 
           
Revenue          
Other  $     $   
Singapore   7,468       
  United States            
   $7,468   $   
           
Net Loss          
Other  $(36)  $   
Singapore   (195,308)      
  United States   (8,247,971)   (5,916,017)
   $(8,443,315)  $(5,916,017)